4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-111281
General Counsel and Secretary sold 3,450 shares at $48.26 ($166,497)
- General Counsel and Secretary acquired 6,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 1 in the form | +6,875 | 94,690 | D | ||
| 2026-03-16 | Sale : show line 2 in the form | −3,450 | $48.26 | $166,497 | 91,240 | D |
| Open-market sales · 3,450 sh · avg $48.26 · $166,497 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-14 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −6,875 | 20,625 | D |
Loading xslF345X05/ownership.xml…